April 27-29, 2027 | Rome Cavalieri

ARM's CEO & Investor Summit

Please join us for the ARM CEO & Investor Summit taking place in conjunction with the Cell & Gene Meeting on the Med. This invitation-only meeting will feature leading investors and analysts sharing insights on the current funding environment for cell and gene therapy companies with the invited group of CEOs. This is also meant to provide an opportunity to engage in open discussions with your peers who are facing similar challenges and opportunities in the capital markets. 

 In October 2025, we hosted our inaugural CEO & Investor Summit in Phoenix, AZ with over 150 attendees.  Based on overwhelming positive feedback from our participants, we are thrilled to bring this programming to Europe this April. 

Event Details

Date:  Wednesday, April 29, 2026 

Time:  1:30 – 5:00pm CET  

Venue:  Rome Cavalieri, A Waldorf Astoria Hotel in Rome Italy

Location:  Monte Mario Room (Lobby Level) 

Registration Required:  Registration for the Cell & Gene Meeting on the Med is required for a Summit pass.

*Please note that the Summit is exclusively for invited CEOs of ARM member companies and investors only.  

Questions?

Please contact ARM’s Vice President of Membership & Events Laura Stringham at lstringham@alliancerm.org.

Summit Agenda

Wednesday, April 29

1:30 - 2:40pm | CEO-only Discussion Roundtable

Invited therapeutic developers only; closed to investors and service providers.

2:40 - 2:50pm | Welcome Investors & Invited Service Provider CEOs and Executives

Content Break

2:50 - 3:00pm | Welcome & Introductions

Speakers:

Tim Hunt, CEO, Alliance for Regenerative Medicine (ARM)

Stephen Majors, Vice President, Global Communications, Alliance for Regenerative Medicine (ARM)

3:00 – 3:45pm | The Investor View: Capital Trends Shaping the Sector

Top investors take the stage to breakdown the forces driving today’s CGT investment climate and the signals they’re watching most closely. The conversation will reveal where capital is moving, why, and what it means for companies seeking to raise in the current environment. 

Chair:

Luca Issi, Analyst, RBC Capital Markets 

Speakers:

Daniela Begolo, Managing Director, EQT

Sean Kendall, Partner, ARCH Venture Partners

Paola Pozzi, Partner, Sofinnova Partners

3:45 – 4:30pm | The Company View: Strategies Behind Successful Raises

This discussion offers an inside look at how private and public companies are navigating today’s capital environment and positioning themselves for long‑term success. Hear firsthand as they break down the tactics, timing, and storytelling behind their recent funding successes.

Chair:

Kinnari Patel, CEO, RTW Institute

Speakers:

Petter Björquist, CEO, Verigraft

Ty Howton, COO, Solid Biosciences

Natalia Misciattelli, Ph.D., CEO, AAVantgarde

4:30 – 5:00pm | Networking Reception

Conclude the Summit with a brief reception alongside your fellow attendees.

2025 CEO & Investor Summit

By using this website you agree to accept our Privacy Policy and Terms & Conditions